Buscar resultados de ensayos clínicos
Hemangiosarcoma - 25 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A RANDOMIZED PHASE 3 TRIAL OF TRC105 AND PAZOPANIB VERSUS PAZOPANIB ALONE IN PATIENTS WITH ADVANCED ANGIOSARCOMA Condición: Advanced Angiosarcoma Fecha: 2016-11-29 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced Angiosarcomas Condición: Angiosarcoma Fecha: 2011-02-23 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Cytological Diagnosis of Hepatic Angiosarcoma and Its Histopathologic Correlation Condición: Hepatic Angiosarcoma Fecha: 2017-01-16 |
Recruiting |
Nombre del estudio: Evaluation of Votrient in Angiosarcoma Condición: Angiosarcoma Fecha: 2014-07-29 Intervenciones: Drug: Pazopanib + Paclitaxel pazopanib in combination with paclitaxel in the treatment of patients with |
Active, not recruiting |
Nombre del estudio: Identification, Molecular Epidemiology Angiosarcoma of the Liver France Condición: Angiosarcoma Fecha: 2013-02-06 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Paclitaxel + Bevacizumab (Avastin®) for the Treatment of Metastatic or Unresectable Angiosarcoma Condición:
Fecha: 2010-01-21 Intervenciones: Drug: Paclitaxel in combination with Bevacizumab 15 mg/kg, IV |
Not yet recruiting |
Nombre del estudio: Dose-Finding of Propranolol in Combination With Metronomic Fixed Oral Cyclophosphamide Based on Bivariate Efficacy-tolerability Outcome in Patients With Locally Advanced or Metastatic Angiosarcoma: A Collaborative and Innovative Phase I-II Sequential Trial by the French Sarcoma Group (GSF/GETO) Condición: Angiosarcoma Fecha: 2016-03-29 Intervenciones: Drug: PROPRANOLOL |
Recruiting |
Nombre del estudio: Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma Condición:
Intervenciones: |
Completed |
Nombre del estudio: Trebananib in Treating Patients With Advanced Angiosarcoma That Cannot Be Removed by Surgery Condición:
Intervenciones: |
Recruiting |
Nombre del estudio: Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma Condición:
Intervenciones: Drug: regorafenib Given PO Other Names: |